SH3BP2 has not been previously associated with NAFLD to the best of our knowledge, but it is a target of estrogen receptor 1 according to FANTOM5 adipose tissue gene regulatory network [44], which may support our sex and tissue-specific finding on SH3BP2. The gene discussed is SH3BP2; the disease is metabolic dysfunction-associated steatotic liver disease.